On January 22, 2026, Neocannbio signed an agreement with Oz Medicann Group, an Australian medical hemp specialist, in Sydney, Australia, for the supply of medical hemp raw materials and joint clinical trials.

Through this agreement, Neocannbio will collaborate with not only Oz Medicann Group but also  NICM Heath Research Institute, Sydney University, and others to develop global new drugs based on medical Hemp.